Medytox is taking steps towards
a global biopharmaceutical company.
Global Network
Medytox is currently exporting products to approximately 60 countries including Japan and Brazil. In addition, we are striving to penetrate the market in the US and European countries in the near future. Based on these results, Medytox will show the status as a global leading biopharmaceutical company.
Thailand
Medytox Thailand
MedyCeles
Japan
MDT International, Tokyo
South Korea
서울본사
Taiwan
Medytox Taiwan
HongKong
Medytox Hong Kong
US
Luvantas, Irvine
Europe: 4
Middle East: 3
Central Asia: 2
Asia: 7
America: 13
Middle East: 6
Central Asia: 3
Asia: 6
America: 12
Oceania: 1
Europe: 6
Starting from a Taiwan joint venture "Medytox Taiwan", Medytox established
a Hong Kong joint venture "Medytox Hong Kong",
a Thailand joint venture "MedyCeles", and
100% owned local subsidiaries in USA, Japan and Thailand.
Headquarters
Medytox
NUMECO
Domestic Corporation Business
Medytox Taiwan
Taiwan joint venture
Medytox Hong Kong
Hong Kong joint venture
MedyCeles
Thailand joint venture
Medytox Thailand
Thailand subsidiary
MDT International
Japan subsidiary
Luvantas
USA subsidiary
Tel : +82-2-3471-8319 Fax : +82-2-3476-8372 E-mail : yongki_oh@medy-tox.co.kr
E-mail : info@luvantus.com
(Taiwan joint venture)
(Hong Kong joint venture)
(Thailand joint venture)
Tel : +66-2-412-8100 Fax : +66-2-864-8763
E-mail : chung.w@medytox.com
(Thailand subsidiary)
Tel : +66-61-361-2020 E-mail : chung.w@medytox.com
(Japan subsidiary)
Tel : +82-2-6901-5875 Fax : +82-2-3476-8372 E-mail : yypark@medytox.com
